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Adult stem cells (SCs) exist in all tissues that promote tissue growth, regeneration, and healing throughout life. The SC niche 
in which they reside provides signals that direct them to proliferate, differentiate, or remain dormant; these factors include 
neighboring cells, the extracellular matrix, soluble molecules, and physical stimuli. In disease and aging states, stable or tran-
sitory changes in the microenvironment can directly cause SC activation or inhibition in tissue healing as well as functional 
regulation. Here, we discuss the microenvironmental regulation of the behavior of SC and focus on plasticity approaches by 
which various environmental factors can enhance the function of SCs and more effectively direct the fate of SCs. 
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Adult stem cells (SCs) exist in all tissues, where they main-
tain homeostasis and respond to harmful stimuli. Entrusted 
with such an important role, these cells are aided by their 
microenvironment, which provides support and regulatory 
signals. The SC niche, including cell-cell and cell-     
extracellular matrix (ECM) relationships as well as diffusi-
ble signaling factors, can mediate signal transduction [1,2]. 
Recent research has shown that adjacent cells provide criti-
cal cell-cell interfaces and paracrine signaling and that a 
number of signaling molecules have been highly conserved 
from invertebrates to humans [3,4]. Meanwhile, this niche 
can also reprogram the SCs, as it has been shown that an 
experimentally vacated ovarian germline stem cell (GSC) 
niche is a stable structure that is capable of inducing cell 
division in foreign surrounding somatic SCs that give rise to 
ovarian follicle cells and is capable of dedifferentiating ec-
topic follicle progenitor cells in relatively early stages of 
differentiation [5]. This study also suggested that the SC 
fate and function could potentially be controlled by micro-
environments in in vitro systems that artificially recapitulate 
certain elements of the niche. Because of the important role 
of SCs in the body and in plasticity, the source of different 
tissue SCs has been investigated to meet unmet needs in 
conventional medicine (myocardial infarction, diabetes, 
cancer, and Parkinson’s and Alzheimer’s diseases) and re-
generative medicine [68]. However, SCs usually pass 
through two different environmental conditions, from isola-
tion to engraftment. It is unknown how microenvironmental 
effects on SCs constrict their responses to bodily insults and 
how functional SCs can be domesticated in vivo. These 
questions have led to the hypothesis that, according to vari-
ous tissue-specific SC niches and different disease microen-
vironments, mimicking the SC niche will facilitate SC 
self-renewal and controlled differentiation to drive the fast 
and efficient differentiation of other SCs so they can join 
the fight [9].  
In this paper, we review the current understanding of the 
intrinsic environmental characteristics and plastic strategies 
in vitro. By regulating the microenvironment, cell fate can 
be controlled to enhance SC function to improve the clinical 
benefits of SC transplantation.  
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1  Intrinsic environment characteristics 
The SC niche is an anatomical compartment that contains a 
reservoir of SCs that can maintain normal tissue or replen-
ish injured or aged cell populations in response to mecha-
nisms that regulate whether they should remain quiescent, 
undergo self renewal, or differentiate [10]. SC niches are 
composed of four main components: regulatory molecules 
(O2, nutrients, and cytokines), other cells (their three-   
dimensional context, cell-cell contacts, autocrine, and para-
crine signals), the extracellular matrix (immobilized and 
released factors, structure, topology, and stiffness), and 
physical factors (shear flow, compression, stretch, and elec-
trical signals) [11]. Intrinsic microenvironments orchestrate 
both systemic and local signals to determine the fate and 
function of SCs. In this section, we discuss the common 
elements of SC niches, including cell-cell, cell-ECM, and 
diffusible signaling factor mediated signal transduction and 
their regulation of SC fate. 
1.1  Cell-cell interactions  
Direct interactions between SCs and adjacent cells, either 
through adherence or gap junctions, are key elements in the 
native SC microenvironment and are required to modulate 
SC retention and distribution [12,13]. By observing 
E-cadherin protein expression in differentiation-defective 
GSCs, Nagaoka et al. found that unregulated E-cadherin 
protein expression led to GSC cell proliferation competition, 
such that differentiated GSCs are forced out of their niche 
by the downregulation of E-cadherin by neighboring SCs. 
Such competition with E-cadherin may serve as a quality 
control mechanism to ensure that the niche is always occu-
pied by functional SCs [14]. Other studies have shown that 
classical E-cadherins, N-cadherins, are more highly ex-
pressed in the brain and are present in neurogenic niches 
[1517]. Porlan et al. found that N-cadherin-mediated adhe-
sion to ependymocytes contributes to the quiescence of 
NSC cells in the SEZ (subependymal zone) niche. At the 
same time, they also showed that the membrane-type met-
alloproteinase MT5-MMP, which can cleave N-cadherin in 
other cell types, regulates the N-cadherin-mediated adhesive 
properties of neural stem cells (NSCs) under physiological 
and regenerative conditions and is necessary for the proper 
activation of NSCs [18]. Furthermore, Ephrin and Notch 
receptors and their ligands are other classes of integral 
membrane proteins that are involved in cell contact mediat-
ed signaling between SCs and their surroundings [1921]. 
For example, Ottone et al. found that direct cell-cell interac-
tions with endothelial cells can enforce quiescence and 
promote NSCs in the vascular niche of mice through endo-
thelial ephrinB-2 and Jagged-1 mediation. Ephrin-mediated 
cellular contact between NSCs and their neighboring cells 
has been proposed to modulate the signaling involved in 
neurogenesis and NSC self-renewal in the adult brain. En-
dothelial cells form a critical part of the vasculature niche 
and involve SC maintenance [21]. Although the direct in-
teractions, through either adherence or gap junctions, be-
tween the SCs and adjacent cells are not understood com-
pletely, it is believed that such interactions are important to 
more directly convey information to the SCs or to feedback 
to the microenvironment cells to participate in repairs or 
signal regulation.  
1.2  Cell-ECM interactions 
SCs reside in a dynamic, specialized microenvironment (the 
SC niche) that provides a three-dimensional extracellular 
network that surrounds all cells, organs and tissues in the 
body. This network forms a biophysical filter for protection 
and nutrition and serves as a medium for facilitating im-
mune responses, angiogenesis and tissue regeneration 
[22,23]. The niche ECM components, including laminin, 
fibronectin and collagen, provide a physical framework and 
instructive signals that regulate SCs. As they serve an adhe-
sion function in the ECM, integrins are involved in the di-
rect binding to a number of ECM components or to other 
cell surface adhesion molecules and receptors [24,25]. In 
the epidermis, skin-specific ablation of the β1-integrin gene, 
attenuated due to an expansion of epidermal SCs following 
increases in β1-integrin expressing keratinocytes, could be 
further accelerated in situations of increased keratinocyte 
proliferation, such as wound healing. In addition, integrins 
can regulate downstream signaling via focal adhesion ki-
nases (FAKs) and phosphoinositide 3-kinase (PI3K), which 
are important for SC self-renewal and proliferation [26]. 
NSCs are embedded in the laminin-rich ECM and express 
various integrin molecules. Blocking the function of specif-
ic integrins in the NSCs using neutralizing monoclonal an-
tibodies enhances precursor proliferation and migration and 
promotes the depletion of NSCs from the niche [27]. In ad-
dition, in a cutaneous epithelial SC microenvironment, 
Kindlin-1 can trigger integrin to regulate the proliferation 
and differentiation of cutaneous epithelial SCs by mediating 
transforming growth factor-β (TGF-β) activation and inhib-
iting Wnt/β-catenin signaling. This occurs through the in-
tegrin-independent regulation of Wnt ligand expression that 
controls SC quiescence and proliferation [28]. The mechan-
ical properties of the ECM are determined by a network of 
collagen, fibronectin and fibrin fibrils differing in length 
and stiffness. Differences in the rigidity of the extracellular 
environment lead to an intracellular feedback mechanism 
that regulates the corresponding levels of generated pulling 
forces and tunes the sensitivity of the focal adhesions to the 
applied force [29]. Research shows that in longer cultures of 
up to 14 days, human MSCs (h-MSCs) selectively differen-
tiate based on the culture period before or after stiffening, 
such that adipogenic differentiation is favored for later 
stiffening, while osteogenic differentiation is favored for 
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Figure 1 (color online)  Schematic representation of the regulatory network of the SC niche that coordinates the balance between stem cell self-renewal and 
differentiation in normal, aging and disease microenvironments. 
earlier stiffening. Changes in the tissue stiffness with time 
could be highly relevant in vivo [30]. Maturation of the 
mesoderm into adult myocardium results in a considerable 
increase in the tissue stiffness. When this is mimicked in 
hydrogels, pre-cardiac cells exhibit increased expression of 
mature cardiomyocyte markers and form more muscle fi-
bers [31]. This functions to provide signal transduction 
pathways for SCs by the ECM. By examining SC-ECM 
interactions at single-cell resolution, it has been possible to 
map the signaling mechanisms that mediate the different SC 
responses [32,33]. Some examples of the interplay between 
integrins and other signaling molecules have been demon-
strated in NSCs and in mammary SCs, where β1-integrins 
were shown to regulate self renewal and differentiation by 
controlling the activity of Notch and epidermal growth fac-
tor (EGF) receptor [34]. Moreover, β1-integrins were also 
found to be essential for regulating the proliferation of in-
testinal SCs (ISCs) by mediating Hedgehog signaling [35]. 
By contrast, when human epidermal SCs differentiate on 
ECM-coated hydrogels of low bulk stiffness, the differenti-
ation signal is mediated by a failure of integrins to cluster in 
focal adhesions. This results in decreased extracellular sig-
nal-regulated kinase (ERK) and mitogen-activated protein 
kinase (MAPK) signaling and increased amphipathic pro-
tein-1 (AP1) activity, which is thought to be due to the re-
duced activity of a phosphatase that acts on JUN N-terminal 
kinase (JNK) [36]. Thus, the ECM within the SC niche acts 
to build the niche architecture and control the balance be-
tween cell renewal and differentiation by functionally and 
physically interacting with growth factor and cytokine re-
ceptors, thereby generating a network of signaling pathways 
in the SC niche. 
1.3  Cell-soluble protein factor interactions 
In the SC niche, soluble protein factors are important ele-
ments that regulate SC behavior [37]. Many studies have 
investigated the role of these cytokines and growth factors, 
as the immobilization of soluble factors in the ECM plays 
an important role in mediating their biological effects in 
vitro. Immobilized soluble protein factors can alter their 
local effective concentration, bioavailability, and stability, 
thereby modulating their effect on target cells. Previous 
studies have shown that fibroblast growth factor-2 (FGF2) 
can activate stress-induced DNA repair to maintain the ge-
nomic integrity of keratinocyte SCs [38]. Examples of sig-
naling proteins that are known to undergo such modifica-
tions include Sonic hedgehog (Shh) and the wingless-type 
MMTV integration site family (Wnt), which both have im-
portant regulatory functions in neural SC niches [39,40]. 
Studies show that Wnt3 is strongly expressed in dentate 
gyrus (DG) hilar cells and in cultured hippocampal astro-
cytes and that GSK3β/β-catenin-signaling is active in the 
adult subgranular zone (SGZ) and the dentate granule cell 
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layer [41]. Notch regulates the maintenance of adult NSCs 
by promoting cell cycle exit and decreasing the adult neural 
progenitor pool [42]. TGF-β can inhibit the expansion of 
NSCs and keep hematopoietic stem cells (HSCs) in their 
quiescent state, and some studies have shown that TGF-β is 
critical for the maintenance of the pluripotency of hESCs 
via Smad2/3 signaling [43]. Thus, soluble factors clearly 
play an important role in SC growth and differentiation in 
the stem cell niche. Even if these factors can easily be added 
or removed from culture systems, their complex mecha-
nisms must still be explored for use in SC applications. 
2  Environmental changes: aging and disease 
2.1  The aging microenvironment 
The regeneration of adult tissues is supported by rare popu-
lations of SCs that continuously divide, self-renew and dif-
ferentiate. This process is tightly regulated by signals ema-
nating from ambient cells to fulfill the dynamic demands of 
the tissue. One hallmark of aging is slow and aberrant tissue 
regeneration, which occurs due to the deteriorated function 
of stem and supporting cells [44]. Telomeres are repetitive 
nucleotide sequences at the end of each chromosome that 
allow for DNA replication without a loss of genetic infor-
mation. Telomere shortening occurs along with organismal 
aging [45]. In Drosophila, it has been found that in aged 
organisms, 90% of the intestinal gene expression patterns 
are altered and the ISCs hyper-proliferate and cause aber-
rant lineage differentiation as well as an accumulation of 
incorrectly differentiated daughter cells. These changes are 
largely caused by an accumulation of oxidative stress and 
are attributed to two signaling pathways: the vascular endo-
thelial growth factor (VEGF) pathway and the Jun 
N-terminal kinase (JNK) pathway. These studies also partly 
explain the decreased regenerative capacity of SCs during 
aging [4648]. In mammals, Guillot et al. [49] found that 
MSCs from younger donors have longer telomeres, allow-
ing for more protracted in vitro expansion. Aside from a 
decrease in the overall expansion potential, several groups 
have also documented that MSCs from older donors have a 
slower proliferation rate, from the initial cell passage until 
the culture senesces [50]. Some studies have assessed the 
differentiation capacity towards the adipo-, osteo- and 
chondrogenic lineages using bone marrow mesenchymal 
stem cells (BM-MSCs) of various ages. The frequency of 
bipotent clones (with osteo- and chondrogenic potential) 
decreased with age, and a higher relative frequency of bi-
potent clones was found in younger donors compared to 
older donors. Conversely, older donors had a relatively 
higher frequency of tri-potent clones [51]. Several studies 
have also assessed tissue regeneration in young mice com-
pared to aged mice. Using the distraction osteogenesis 
model, aged mice were found to have increased circulating 
serum levels of IL-6 and TNF-α and a 60% reduction in 
bone formation compared to young mice [52]. SCs reside in 
a very complex environment that shows age-related changes. 
All of these factors can easily interfere with the biological 
properties of SCs, leading SCs to age or senesce by failing 
to provide the right signals.  
2.2  Disease microenvironment 
In disease states, activation and inhibition signals in the 
microenvironment cause continued or transitory changes 
that directly alter SC function [53]. Hence, SCs show dif-
ferent roles in different diseases, including immune regula-
tion, functional regulation, trophic action, and differentia-
tion. However, along with the continuous disease, the envi-
ronment of the SCs causes them to gradually lose their 
function. Humans with type II diabetes have reduced num-
bers of circulating peripheral blood mononuclear cells that 
express osteocalcin. They also have elevated levels of se-
rum sclerostin and reduced levels of serum β-catenin. In 
animal experiments, streptozotocin has been used to break 
insulin-producing beta cells in the pancreas and thus pro-
duces a disease that mimics type I diabetes [54,55]. In a rat 
model of streptozotocin-induced diabetes, the proliferation 
of chondroprogenitor cells is similarly reduced at 
post-fracture days 4 and 7, with decreased cartilage for-
mation and delayed union [56,57]. The potential for endos-
teal bone formation is also diminished in the streptozoto-
cin-treated diabetic rat model, in which bone growth into 
titanium-coated femoral implants is reduced compared to 
the level of osseointegration in control rats [57]. In chronic 
wound patients, such as patients with diabetes, chronic renal 
failure, and arterial or venous insufficiency, these effects 
likely include impaired inflammatory cell migration, re-
duced growth factor production, and poor tissue remodeling. 
Rodriguez-Menocal et al. [58] studied fibroblasts derived 
from normal donors and chronic wound patients that were 
co-cultured after an in vitro scratch assay. They found that 
the migration ability was significantly reduced in the fibro-
blast treatment of BM-MSCs from chronic wound patients 
compared to MSCs from normal donors. During injury, the 
support cells are able to activate a repair program, recapitu-
lating aspects of development in the area of damage. These 
areas become permissive for SC renewal, migration and 
differentiation. In their research, Ito et al. [59] found that a 
wound microenvironment can trigger the regeneration of 
SCs involved in hair follicles by activating the Wnt signal-
ing pathway. The wound microenvironment leads to the 
activation of certain signaling pathways, driving SC prolif-
eration and differentiation towards wound healing and hair 
regeneration. The studies also revealed that different dis-
eases inevitably led to changes in the microenvironment, 
depending on the characteristics of the changing environ-
ment and the domestication of functional cells in vitro. 
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3  Management of the microenvironment en-
hances SC function 
SC microenvironments are becoming increasingly appreci-
ated due to their therapeutic effects in regulating SC behav-
ior and homeostasis. In their niche, SCs are maintained or 
can undergo proliferation and differentiation in response to 
injury, disease, or aging to replenish lost cells or tissues [6]. 
In different environments, SCs have different requirements 
to function properly. Therefore, plastic SCs and progenitor 
cells have been studied in a variety of environments and 
have been produced through physical, chemical, genetic, 
and pharmacological manipulations. In suitable microenvi-
ronments, plastic SCs generally have improved cell survival, 
increased neuronal differentiation, and enhanced paracrine 
effects, leading to increased trophic support, improved 
homing to the lesion site, and intensive suppression in-
flammatory factors and immune responses to promote func-
tional recovery (Figure 2) [60,61]. The microenvironment 
serves to drive the cells into a state of readiness in different 
environments. 
3.1  Enhanced cell survival  
The survival ability of the transplanted cells depends on the 
treatment effects after the cell is transplanted in vivo. The 
ischemic, oxygen-lacking, inflammatory, cytokine-rich, 
high glucose, and high adipose microenvironment is harsh, 
offering a significant challenge to the transplanted donor 
SCs [6163]. Massive cell death thus occurs during trans-
plantation and following engraftment, which significantly 
lowers the effectiveness of the clinical therapy. The simu-
lated hypoxia microenvironment triggers the improved sur-
vival of the SCs in vitro and after transplantation [62,64]. 
Studies show that sub-lethal levels of hypoxia can signifi- 
cantly increase the tolerance of treated cells to apoptotic and 
other insults in vitro as well as in the harsh environments of 
the ischemic and adjacent regions. BM-MSCs from GFP 
transgenic mice that were cultured under hypoxic conditions 
(0.5% oxygen) show significant increases in the expression 
of hypoxia inducible factor 1 (HIF-1a), angiopoietin-1, 
erythropoietin (EPO), erythropoietin receptor (EPOR), an-
ti-apoptotic proteins Bcl-2, and Bcl-xL and a decrease in the 
amount of active caspase-3. The transplantation of MSCs 
with hypoxic treatment into a region affected by myocardial 
infarction have a lower level of cell death and apoptosis at 
24 h and delayed MSC cell death to 6 W [65]. Another 
study showed that hypoxia microenvironment induced au-
tophagy could reduce apoptosis of BMSCs in ischemia and 
hypoxia/serum deprivation (H/SD) environment by increas-
ing the activity of leptin signaling modulate AMPK and 
mTOR pathway [66]. The lipopolysaccharide (LPS) micro-
environment can decrease connexin-43 (CX43) expression 
in MSCs, enhancing the survival of MSCs under hypoxia 
and serum deprivation (Hypoxia/SD) conditions. The mod-
ulating mechanism may be related to the ERK signaling 
pathway. Hypoxia and LPS strengthened the power of 
MSCs against the inflammatory and hypoxia environment, 
enhancing survival in the target area [67]. The plasticity of 
the external microenvironment can be effective in enhanc-
ing cell survival. 
3.2  Enhanced secretion effects 
Recent clinical trials have focused on the ability of MSCs to 
exert their biological function through the paracrine and 
autocrine actions of secreted cytokines. SCs secrete a varie-
ty of factors that support regenerative processes in damaged 
tissue, induce angiogenesis, protect cells from apoptotic cell 
death and modulate the immune system [68]. For example, 
studies have now shown that MSC protein extracts or con-  
 
 
Figure 2 (color online)  SC application strategy. SCs are isolated from their native tissue and cultured. The culture conditions were strategically optimized 
to expand or alter the niches that increase efficiency in vivo in transplant recipients. 
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ditioned medium collected from MSC cultures can produce 
many of the same beneficial effects as MSCs on the 
post-infarction heart and in damaged liver tissues [69,70]. 
MSCs appear to secrete VEGF and basic fibroblast growth 
factor (bFGF) upon contacting the injured myocardium, 
which stimulates the formation of new vessels and increases 
the capillary density to increase/restore blood flow to the 
infarcted region [71]. However, the secretory activity of 
MSCs strongly depends on their tissue microenvironmental 
conditions. After treatment with growth factors, hypoxia or 
pharmacological agents, plastic MSCs show increased 
paracrine effects within their microenvironment. Hypoxic 
exposure increases the expression of stromal cell-derived 
factor-1 (SDF-1), chemokine receptor-4 (CXCR4), 
brain-derived neurotrophic factor (BDNF), VEGF, EPO and 
EPOR in MSCs. These factors have been shown to share the 
same trophic mechanisms that are essential for the roles of 
grafted SCs, which are necessary for their survival. Upreg-
ulated factors may include angiopoietin-I, VEGF, hepato-
cyte growth factor (HGF), placental growth factor (PlGF), 
BDNF, and fibroblast growth factor-2 (FGF-2) [65,72,73]. 
Treatment using some of these recombinant proteins or the 
induced endogenous expression of these proteins to enhance 
the secretion effects can reduce neuronal death and promote 
angiogenesis and attenuate many pathophysiological 
changes. 
3.3  Enhanced migration and homing  
The factors released upon tissue damage or apoptosis mobi-
lize and recruit stem and progenitor cells to the damaged 
site, where they proliferate and differentiate, eventually 
replacing the damaged tissues [60]. To respond to migratory 
signals released in the sites of injury, the SCs must express 
surface receptors capable of sensing those signals. Thus, 
increased regenerative and repair potentials were related 
with the enhanced migration and homing of the SCs to the 
lesion sites. Various studies attempting to modify the SCs or 
to enhance their expression of surface receptors to increase 
SC migration have been performed. Many studies have fo-
cused on ways to enhance the functional expression of 
CXCR4 in MSCs to increase their migration toward chem-
otactic SDF-1α secreted at injury sites [74]. For example, an 
environment rich in H2O2 is reported to increase the migra-
tion of MSCs through the upregulation of CXCR4 and the 
activation of ERK [75]. Hypoxic conditions can signifi-
cantly promote the formation of the FAK-Kv2.1 complex, 
increasing focal adhesion kinase (FAK) phosphorylation 
and upregulating CXCR4 in MSCs. All of these hypoxic 
effects reinforce the migration capacity and the homing of 
transplanted cells to the lesion sites [73]. Maijenburg et al. 
[76] investigated the process of MSC migration and found 
that nuclear receptors Nur77 and Nurr1 showed the highest 
expression in migratory MSCs. The expression of these 
receptors rapidly increased under stimulation with SDF-1α 
and platelet-derived growth factor (PDGF). Genetically 
engineered MSCs overexpressing Nur77 or Nurr1 showed 
enhanced migration toward SDF-1α.  
3.4  Increased differentiation potentials 
The differentiation potentials of SCs are increased follow-
ing migration and homing using tissue transplanted to the 
lesion sites. Differentiated SC-derived cells, such as osteo-
genic cells, have been used to treat osteogenic imperfecta 
patients, as chondrogenic cells in knee cartilage repair, as 
mesangial cells for the repair of post-glomerular injuries 
and as myocardiocytes for heart regeneration [7779]. SC 
division and differentiation into lineage-specific cells occurs 
through processes controlled by a combination of the intrin-
sic fluctuations of protein concentrations and gene state 
fluctuations occurring through promoter binding. These 
conditions can be influenced by changes in the microenvi-
ronment, including the introduction of chemical agents or 
growth factors, physical or mechanical stimulation; changes 
in the cell density, cell-cell attachments and cell-cell inter-
actions; and the direct introduction of regulatory genes into 
the cells [8083]. Studies have shown that bone morphoge-
netic proteins (BMPs) play a significant role by initiating 
chondrogenesis and differentiation of bone [2]. The ERK1/2 
pathway-mediated differentiation of insulin-like growth 
factor-1 (IGF-1) transfected spinal cord-derived neural SCs 
into oligodendrocytes. IGF-1 can promote the proliferation 
and osteogenic differentiation of human dental pulp SCs via 
the mTOR pathway [84]. Hypoxic preconditioning of the 
hMSCs can effectively restore osteogenic differentiation, 
benefitting transplantation therapy for bone regeneration 
[85]. HIF-1a regulates transcriptional genes involved in the 
differentiation of bone marrow SCs into cardiomyocytes 
[86]. Natural and synthetic biomaterials provide 
three-dimensional differentiation niches to guide the differ-
entiation of SCs towards specific lineages. Bioceram-
ic-collagen scaffolds loaded with human adipose-tissue de-
rived SCs enhanced bone regeneration and reconstruction 
and also served as appropriate structures in bone regenera-
tive medicine [87]. Furthermore, the combination of bio-
chemical and biophysical stimulatory signals in a 
three-dimensional setting could potentially enhance the de-
velopment of mature osteoblasts [88]. A chitosan-gelatin 
hydrogel containing TGF-β1 was used to promote chondro-
genesis, while a polylactic-co-glycolic acid (PLGA) scaf-
fold loading BMP-2 was used to promote osteogenesis 
[89,90].  
3.5  Enhanced immune regulation 
Inflammatory and immune responses in tissues may pose 
secondary and continuous danger to transplanted cells. SCs 
affect tissue regeneration by modulating inflammation, 
which has revolutionized SC therapy for the treatment of 
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inflammatory diseases [63]. For example, the transplanta-
tion of SCs for the treatment of myocardial infarction (MI) 
also suppresses inflammatory responses by significantly 
decreasing myocardial proinflammatory signaling mole-
cules, including tumor necrosis factor-α (TNF-α) and inter-
leukin-6 (IL-6) [91]. In fact, different inflammatory states 
can result in markedly different responses to SC treatment, 
which indicates the plasticity of MSC immunomodulation. 
In a non-inflammatory environment, bone marrow derived 
murine MSCs constitutively express low levels of cycloox-
ygenase-2 (COX-2), prostaglandin-2 (PGE-2), TGF-β1 and 
HGF, but not IL-10, programmed death-1 (PD-1), PD-L1 or 
PD-L2. In a pro-inflammatory environment, interferon-γ 
(IFN-γ) and IDO expression induced PD-L1 expression, 
which upregulated and enhanced their immunosuppressive 
effects after transplantation [92]. We have examined the 
expression of many pro-inflammatory cytokines/chemo- 
kines in BMSCs subjected to hypoxia treatment and ob-
served down-regulated genes, such as CCL4, CXCR3 
CXCL10, CC3, CC5 and CC17. In hypoxic preconditioned 
MSCs, the expression of IL-1β, IL-6, OX-42 and TNF-α is 
remarkably reduced. After intravenous injection into adult 
rats 24 h after ischemic stroke, hypoxia-preconditioned 
BMSCs show a greater ability to suppress microglial activ-
ity in the brain compared to normoxia-treated cells [93]. 
Studies have suggested that the secretion of immunomodu-
latory factors by MSCs can be enhanced by three-dimen- 
sional aggregation or pro-inflammatory cytokine treatment. 
Ge et al. [94] showed MSC spheroids that were forced to 
aggregate in agarose can significantly increase the secretion 
of immunomodulatory paracrine factors, IDO activity and 
IL-6 secretion. 
3.6  Anti-SC aging 
SCs are extremely rare in primary tissues. Thus, the in vitro 
expansion of SCs has become an inevitable option. Howev-
er, after a certain number of cell divisions, SCs enter senes-
cence and stop proliferating, showing an enlarged and flat-
tened cell shape [95]. Previous studies have shown that hu-
man MSCs exhibit reduced differentiation potentials in vitro 
and that the replicative senescence of MSC preparations 
begins with the first passage [51]. Thus, the difficulty in the 
long-term expansion of MSCs using standard culture sys-
tems without the loss of their SC properties suggests that a 
critical feature of their microenvironment that is necessary 
for the retention of SC properties is absent in these culture 
systems. Lai et al. [96] reconstituted a cell-free ECM of 
native ECM to culture human marrow cells consisting of 
collagen I and III; fibronectin; small leucine-rich proteo-
glycans, such as biglycan and decorin; and major compo-
nents of the basement membrane, such as the large molecu-
lar weight proteoglycans perlecan and laminin. The results 
show that the ECM strongly promoted their proliferation, 
retained their SC properties with a low level of reactive ox-
ygen species (ROS), and substantially increased their re-
sponses to BMP-2. Meanwhile, the bone formation capacity 
of cells expanded on plastic was dramatically diminished 
after 6–7 passages [96]. The main components of natural 
Wharton’s jelly extract (WJE) contain ECM proteins, such 
as collagen and fibronectin, and cytokines, such as IGF-I 
and bFGF. Using WJE, Hao [97] developed a culture that 
efficiently suppressed the enhancement of intracellular ROS, 
p53, and p16INK4a/pRb in MSCs. Their data demonstrated 
that WJEs can provide the ideal microenvironment for MSC 
culture expansion in vitro, preserving MSC properties by 
delaying senesce. Another study found that cell contact ac-
celerated the development of replicative senescence during 
culture. MSCs in contact cultures (with cell passages per-
formed at 100% confluence) reached cellular senescence 
earlier than in noncontact culture conditions (with subcul-
tures at 60%70% of confluence), and the doubling time 
was significantly prolonged. These results show that cell 
contact induced accelerated senescence in MSCs, accompa-
nied by ROS accumulation due to defective ROS clearance 
and Ras and p16 (INK4a) upregulation. These changes play 
an important role in contact-induced senescence in MSCs, 
independent of telomere shortening and p53 [98]. Cell con-
tact leads to direct cell-cell actions against SC aging in vitro, 
and it remains to be determined whether this is related to 
cell-cell adherence or gap junctions in vivo. The SC micro-
environment is dynamic and intricate, and SC behaviors are 
governed by microenvironment changes in vivo. The present 
study demonstrated that even small changes in the environ-
ment will affect the SC fate. Thus, another important re-
maining question is how to choose suitable microenviron-
ments for the expansion of high quality SCs.  
4  Perspectives 
Undoubtedly, SC therapy has become an attractive method 
of regenerative medicine. However, recent clinical trials 
have focused on the ability of MSCs to exert their biological 
function through the paracrine and endocrine actions of se-
creted cytokines. Thus, using the environment to enhance 
the secretory effect of SCs is increasingly important. 
Meanwhile, several questions must be answered in the fu-
ture to improve the current SC applications. (i) How does 
the use of biomaterials resemble the role of natural ECMs in 
integrating the building blocks of these complex systems, 
including the physical properties of the scaffold structure, 
the spatial and temporal control of bioactive factor delivery, 
and the construction of a three-dimensional microenviron-
ment to enhance MSC survival and function? (ii) How can 
the characteristics of disease microenvironments be used to 
manipulate SC plasticity in vitro and to obtain functional 
cells with more speed and accuracy? (iii) How can we assist 
SCs to grow from a young state to a large-scale expansion, 
or to reverse from an aged to a young state? Continuing to 
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explore the SC niche will hopefully improve our ability to 
better characterize SC fate decisions and more effectively 
develop clinical treatment. Thus, the integration of these 
different elements will allow us to construct SC microenvi-
ronments to better characterize SC fate decisions and more 
effectively develop robust culture systems. 
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